13 The primary core analysis compared initial therapy with either agent, including patients in the sequential arms who received either letrozole or tamoxifen for the first 2 years, and included events occurring up to 30 days after the treatment switch; combining these patient groups increased the statistical power for the letrozole versus tamoxifen comparison
msd stromectol
